Detalhe da pesquisa
1.
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Cell
; 173(7): 1770-1782.e14, 2018 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29906450
2.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med
; 390(15): 1359-1371, 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38631003
3.
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet
; 402(10407): 1043-1051, 2023 09 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37524096
4.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med
; 385(8): 683-694, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34407342
5.
Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients.
Gastrointest Endosc
; 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38272276
6.
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
J Natl Compr Canc Netw
; 22(1): 4-16, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38394781
7.
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.
Proc Natl Acad Sci U S A
; 118(24)2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34099557
8.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36382533
9.
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer.
J Urol
; 209(1): 121-130, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36317715
10.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
J Urol
; 209(4): 701-709, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36573926
11.
Integrative clinical genomics of metastatic cancer.
Nature
; 548(7667): 297-303, 2017 08 17.
Artigo
Inglês
| MEDLINE | ID: mdl-28783718
12.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Cancer
; 128(6): 1194-1205, 2022 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34882781
13.
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.
Lancet
; 397(10275): 695-703, 2021 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33592176
14.
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 990-1000, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35767205
15.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34597472
16.
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(1): 71-90, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34991070
17.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(7): 931-945, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34051178
18.
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
Cancer
; 127(12): 1965-1973, 2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33690902
19.
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
J Urol
; 206(1): 52-61, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33634707
20.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
BJU Int
; 128(5): 607-614, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33909949